Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors

Journal of Clinical Oncology

Volumn 10, Issue 6, 1992, Pages 990-994

  Wiebe, Valerie J ^a   Osborne, C Kent ^a   McGuire, William L ^a   DeGregorio, Michael W ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ANIMAL TISSUE; ARTICLE; BREAST TUMOR; DRUG ACCUMULATION; DRUG RESISTANCE; EXPERIMENTAL MODEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SENSITIVITY; ISOMERISM; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE; FEMALE; HUMAN; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SPECTRUM ANALYSIS, MASS; TAMOXIFEN;

EID: 0026632964     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.6.990     Document Type: Article

References (18)

1. Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25:127-205, 1984
2. Leinster SJ, Shabib H, Farquharson RG, et al: Is tamoxifen oestrogenic to the human endometrium? Breast Cancer Res Treat 19:174, 1991 (abstr)
3. Jordan VC, Robinson SP, Welshons WV: Resistance to antiestrogen therapy, in: Kessle D (ed): Drug Resistance. Boca Raton, FL, CRC Press 1987, pp 403-427
4. Adam HK, Douglas EJ, Kemp JV: The metabolism of tamoxifen in humans. Biochem Pharmacol 27:145-152, 1979
5. Kemp JV, Adam HK, Wakeling AE, et al: Identification and biological activity of tamoxifen metabolites in human serum. Biochem Pharmacol 32:2045-2082, 1983
6. Jordan VC, Bain RR, Brown RR, et al: Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer. Cancer Res 43:1446-1458, 1983
7. Lyman SD, Jordan VC: Metabolism of tamoxifen and its uterotrophic activity. Biochem Pharmacol 34:2787-2794, 1985
8. Fromson JM, Pearson S, Bramah S: The metabolism of tamoxifen (ICI 46, 474). I. In laboratory animals. Xenobiotica 3:693-709, 1973
9. Gottardis MM, Jiang SY, Jeng MH, et al: Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by a novel steroidal antiestrogens. Cancer Res 49:4090-4093, 1989
10. Osborne CK, Coronado E, Wiebe VJ, et al: Acquired tamoxifen resistance: Correlation with reduced tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J Natl Cancer Inst 83:1477-1482, 1991
11. Osborne CK, Coronado E, Wiebe VJ, et al: Acquired tamoxifen resistance in breast cancer correlates with reduced tumor accumulation of tam and trans-4-hydroxytam. J Clin Oncol 10:304-310, 1992
12. Robertson DW, Katzenellenbogen JA, Long DJ, et al: Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. J Steroid Biochem 16:1-13, 1982
13. Lien EA, Solheim E, Lea OA, et al: Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res 49:2175-2183, 1989
14. Murphy CS, Langan-Fahey SM, McCague R, et al: Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-response T47D breast cancer cells in vitro. Mol Pharmacol 38:737-744, 1990
15. Murphy C, Fotsis T, Pantzar P, et al: Analysis of tamoxifen and its metabolites in human plasma by gas chromatography mass spectrometry (GC-MS) using selected ion monitoring (SLM). J Steroid Biochem 26:547-555, 1987
16. Taylor SG IV, German RS, Falkson G, et al: Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women. Ann Intern Med 104:455-461, 1986
17. Pritchard KI, Thomson DB, Myers RE, et al: Tamoxifen therapy in premenopausal patients with metastatic breast cancer. Cancer Treat Rep 64:787-796, 1980
18. Hoogstraten B, Gad-El-Mawia N, Maloney TR, et al: Combined modality therapy for first recurrence of breast cancer Cancer 54:2248-2256, 1984